Microsatellite Stable (MSS) Colorectal Cancer (CRC) (DBCOND0130188)

Identifiers

Synonyms

MSS, Microsatellite Stable Colon Cancer / Microsatellite Stable Colorectal Cancer / Colorectal Cancer Microsatellite Stable (MSS) / Microsatellite Stable Colon Cancer (MSS) / Microsatellite-stable Colorectal Cancer / Microsatellite-stable Colorectal Cancer (MSS CRC) / Microsatellite-stable Colon Cancer

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04432857	AN0025 and Pembrolizumab Combination in Advanced Solid Tumors	Pembrolizumab	treatment	1	active_not_recruiting
NCT04145193	Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC	Durvalumab Fluorouracil Leucovorin Monalizumab Oleclumab Oxaliplatin	treatment	2	withdrawn
NCT03549000	A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.	No drug interventions	treatment	1	terminated
NCT04895709	A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors	Docetaxel Nivolumab	treatment	1 / 2	recruiting
NCT03891953	Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.	Spartalizumab	treatment	1	active_not_recruiting
NCT04332653	NT-I7 (Efineptakin Alfa) in Combination with Pembrolizumab in Participants with Advanced Solid Tumors	Efineptakin alfa Pembrolizumab	treatment	1 / 2	active_not_recruiting
NCT06444815	A Study of VET3-TGI in Patients With Solid Tumors	Pembrolizumab	treatment	1	recruiting
NCT02060188	A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread	Cobimetinib Daratumumab Ipilimumab Nivolumab Relatlimab	treatment	2	active_not_recruiting
NCT04060342	GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma	Gemcitabine Paclitaxel Pembrolizumab	treatment	1	terminated
NCT04301011	Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors	Pembrolizumab	treatment	1 / 2	terminated
NCT03104439	Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer	Ipilimumab Nivolumab	treatment	2	recruiting
NCT03473925	Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)	Navarixin Pembrolizumab	treatment	2	completed
NCT03658772	Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer	Grapiprant Pembrolizumab	treatment	1	completed
NCT03207867	A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma	Spartalizumab Taminadenant	treatment	2	terminated